Psoriasis | Arcutis | ARQ-151-306
Pharmaceutical Company/Sponsor:
Arcutis
Code:
ARQ-151-306
Title:
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Subjects With Chronic Plaque Psoriasis Who Have Completed Preceding Studies ARQ-151-301 or ARQ- 151-302
Type:
Interventional
Phase:
3
Condition/Disease:
Psoriasis
Intervention(s)/Treatment(s):
Drug: Topical roflumilast
Status:
Enrolling by Invitation
Link for Additional Information:
